Risk of adverse drug reactions by time period from the start of raltegravir treatment.</p
<p>Adverse Drug Reaction (ADR) Rate According to ADR Risk Score Derived From Model 4.</p
OBJECTIVE: To characterize and compare the rates of adverse drug reactions (ADRs) and interactions o...
Adverse drug reactions (ADRs) initiate about 3,5% of hospitalization, quite often it results in fata...
To compare the frequency and risk factors of toxicity-related treatment discontinuations between ral...
<p>Frequency of Serious Adverse Drug Reactions by HIV status and months of treatment.</p
<p>Treatment-emergent adverse events experienced by ≥5% of patients in either treatment group (treat...
Incidence of adverse events during on-treatment follow-up and whole study period.</p
<p>Relative risk of adverse events in randomized controlled trials with bee venom therapy and saline...
<p>Adverse drug reactions in MDR-TB/HIV co-infected patients under treatment.</p
<p>Number and percentages of subjects showing adverse events after administration of drugs in differ...
The occurrence of adverse events after receiving the first and second dose in the participants with ...
The occurrence of adverse events after receiving the first and second dose in the participants with ...
Most of the available information on long-term toxicity of regimens based on raltegravir and/or mara...
Most of the available information on long-term toxicity of regimens based on raltegravir and/or mara...
<p>Mortality rates in time periods after commencement of anti-retroviral therapy.</p
<p>Adverse Drug Reaction (ADR) Rate According to ADR Risk Score Derived From Model 4.</p
OBJECTIVE: To characterize and compare the rates of adverse drug reactions (ADRs) and interactions o...
Adverse drug reactions (ADRs) initiate about 3,5% of hospitalization, quite often it results in fata...
To compare the frequency and risk factors of toxicity-related treatment discontinuations between ral...
<p>Frequency of Serious Adverse Drug Reactions by HIV status and months of treatment.</p
<p>Treatment-emergent adverse events experienced by ≥5% of patients in either treatment group (treat...
Incidence of adverse events during on-treatment follow-up and whole study period.</p
<p>Relative risk of adverse events in randomized controlled trials with bee venom therapy and saline...
<p>Adverse drug reactions in MDR-TB/HIV co-infected patients under treatment.</p
<p>Number and percentages of subjects showing adverse events after administration of drugs in differ...
The occurrence of adverse events after receiving the first and second dose in the participants with ...
The occurrence of adverse events after receiving the first and second dose in the participants with ...
Most of the available information on long-term toxicity of regimens based on raltegravir and/or mara...
Most of the available information on long-term toxicity of regimens based on raltegravir and/or mara...
<p>Mortality rates in time periods after commencement of anti-retroviral therapy.</p
<p>Adverse Drug Reaction (ADR) Rate According to ADR Risk Score Derived From Model 4.</p
OBJECTIVE: To characterize and compare the rates of adverse drug reactions (ADRs) and interactions o...
Adverse drug reactions (ADRs) initiate about 3,5% of hospitalization, quite often it results in fata...
DOI
Add to ORKG